QUBTS is significantly overvalued at $7B market cap with only $2-3M quarterly revenue (P/S of 660), declining YoY revenue, and worsening negative operating cash flow. The post cites lack of insider buying for 3 years and technical setup suggesting retest of $12 and lower, with price target of $4-6 by Jan 27.

QUBTS is significantly overvalued at a 660 P/S ratio with declining revenue, negative and worsening operating cash flow, and insider selling activity. Author predicts the stock will decline to $4-6 by January 27 based on technical analysis and fundamentals.

QUBTS is an overvalued speculative company with a 7B market cap generating only $2-3M quarterly revenue, showing declining YoY sales, deteriorating cash flows, and insider selling signals. The post argues the company's expensive valuation (P/S 660) and operational challenges make it a short candidate.